Mason Street Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-44,191
Closed -$1.47M 1526
2020
Q2
$1.47M Buy
44,191
+4,661
+12% +$155K 0.03% 650
2020
Q1
$1.08M Hold
39,530
0.02% 699
2019
Q4
$780K Buy
39,530
+6,014
+18% +$119K 0.01% 986
2019
Q3
$434K Buy
33,516
+600
+2% +$7.77K 0.01% 1135
2019
Q2
$410K Buy
32,916
+1,279
+4% +$15.9K 0.01% 1159
2019
Q1
$460K Buy
31,637
+1,824
+6% +$26.5K 0.01% 1163
2018
Q4
$329K Buy
29,813
+6,608
+28% +$72.9K 0.01% 1178
2018
Q3
$610K Buy
23,205
+799
+4% +$21K 0.01% 1035
2018
Q2
$458K Buy
22,406
+1,085
+5% +$22.2K 0.01% 1107
2018
Q1
$387K Buy
21,321
+1,454
+7% +$26.4K 0.01% 1130
2017
Q4
$277K Buy
19,867
+560
+3% +$7.81K 0.01% 1231
2017
Q3
$357K Buy
19,307
+2,839
+17% +$52.5K 0.01% 1126
2017
Q2
$278K Buy
16,468
+1,346
+9% +$22.7K 0.01% 1185
2017
Q1
$202K Buy
15,122
+1,154
+8% +$15.4K 0.01% 1275
2016
Q4
$210K Buy
13,968
+1,092
+8% +$16.4K 0.01% 1245
2016
Q3
$151K Buy
12,876
+513
+4% +$6.02K ﹤0.01% 1297
2016
Q2
$134K Buy
12,363
+1,331
+12% +$14.4K ﹤0.01% 1299
2016
Q1
$102K Buy
11,032
+930
+9% +$8.6K ﹤0.01% 1331
2015
Q4
$150K Buy
10,102
+876
+9% +$13K ﹤0.01% 1207
2015
Q3
$151K Buy
9,226
+1,012
+12% +$16.6K 0.01% 1162
2015
Q2
$187K Buy
8,214
+1,791
+28% +$40.8K 0.01% 1113
2015
Q1
$98K Sell
6,423
-128,583
-95% -$1.96M ﹤0.01% 1298
2014
Q4
$1.63M Buy
135,006
+207
+0.2% +$2.49K 0.01% 1029
2014
Q3
$1.53M Sell
134,799
-36
-0% -$408 0.01% 1047
2014
Q2
$1.6M Buy
134,835
+3,196
+2% +$38K 0.01% 1044
2014
Q1
$1.53M Sell
131,639
-1,681
-1% -$19.6K 0.01% 1045
2013
Q4
$2.36M Buy
133,320
+126,555
+1,871% +$2.24M 0.02% 852
2013
Q3
$97K Buy
6,765
+434
+7% +$6.22K ﹤0.01% 1537
2013
Q2
$95K Buy
+6,331
New +$95K ﹤0.01% 1452